AN2 Therapeutics, Inc.
AN2 Therapeutics, Inc.
Your view on ANTX
Overview
What the company does, where it operates, and who runs it.
About AN2 Therapeutics, Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Eric E. Easom
- Headquarters
- 1800 El Camino Real, Menlo Park, CA, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Eric E. Easom
- Headquarters
- 1800 El Camino Real, Menlo Park, CA, US
AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.
Infographics
Visual summary of the business at a glance.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.